Moloney Securities Asset Management’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35,000
Closed -$97K 425
2022
Q3
$97K Buy
35,000
+22,000
+169% +$53.4K 0.02% 353
2022
Q2
$16K Sell
13,000
-5,000
-28% -$8.38K ﹤0.01% 357
2022
Q1
$52K Sell
18,000
-6,000
-25% -$25.5K 0.01% 393
2021
Q4
$161K Buy
+24,000
New +$233K 0.03% 417

Moloney Securities Asset Management's ZY Position: Q4 2022 in Review

Moloney Securities Asset Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 35,000 shares — an estimated $97K sold.

Moloney Securities Asset Management first reported a position in ZY in Q4 2021 and held it in 4 quarters. The position peaked at $161K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Moloney Securities Asset Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Moloney Securities Asset Management sold 35,000 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $97K.
  • Moloney Securities Asset Management first reported a position in Zymergen Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Moloney Securities Asset Management's Zymergen Inc. Common Stock position peaked at $161K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Moloney Securities Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.